The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study

Though most follicular lymphoma biomarkers rely on tumor features, the host genetic background may also be relevant for outcome. Here we aimed at verifying the contribution of candidate polymorphisms of FCγ receptor, DNA repair and detoxification genes to prognostic stratification of follicular lymp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Haematologica
Autores principales: Rossi, Davide, Bruscaggin, Alessio, La Cava, Piera, Galimberti, Sara, Ciabatti, Elena, Luminari, Stefano, Rigacci, Luigi, Tucci, Alessandra, Pulsoni, Alessandro, Bertoldero, Giovanni, Vallisa, Daniele, Rusconi, Chiara, Spina, Michele, Arcaini, Luca, Angrilli, Francesco, Stelitano, Caterina, Merli, Francesco, Gaidano, Gianluca, Federico, Massimo, Palumbo, Giuseppe A.
Formato: Artigo
Lenguaje:Inglês
Publicado: Ferrata Storti Foundation 2015
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4380725/
https://ncbi.nlm.nih.gov/pubmed/25596266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.108183
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares